CTLT Catalent Inc

Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets.

$67.42  +3.15 (4.90%)
As of 03/27/2023 14:09:29 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  07/31/2014
Outstanding shares:  180,090,483
Average volume:  1,939,234
Market cap:   $11,280,867,855
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP96PQ4

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%